Ways to address limitations while also enhancing the decision-making process.
Thani Jambulingam, PhD
Advertisement
A professor of food, pharma, and healthcare business at Saint Joseph’s University’s Erivan K. Haub School of Business.
Articles by Thani Jambulingam, PhD
This link in the pharma supply chain is undergoing a major transformation propelled by technological advancements, regulatory changes, and evolving market dynamics, requiring industry leaders to adopt innovative strategies in order to remain competitive.
With great power comes great responsibility. In this case, tackling these obstacles is vital to making sure that the positives of GLP-1s are not outweighed by the downfalls of improper waste disposal.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Merck Begins Construction on $3 Billion Pharmaceutical Center of Excellence in Virginia
2
Pharma Pulse: Amazon Enters Weight-Loss Drug Market, Merck Expands US Manufacturing, and FDA Approves Tezspire for Chronic Sinusitis
3
HDA 2025 Traceability Seminar: DSCSA Compliance Ushers in a More Secure and Transparent Pharma Supply Chain
4
HDA 2025 Traceability Seminar: FDA Emphasizes Readiness Over Perfection
5
